| Natera, Inc. Common Stock | $59.1b | $405.96 | +0.7% | 1.0M | |
| Illumina Inc | $41.2b | $269.50 | -0.1% | 1.0M | |
| Labcorp Holdings Inc. | $25.0b | $329.39 | -0.3% | 487.3K | |
| 10x Genomics, Inc. Class A Common Stock | $12.2b | $71.37 | +2.4% | 1.9M | |
| Bio-Rad Laboratories, Inc.Class A | $10.1b | $369.94 | +1.8% | 19.2K | |
| QIAGEN N.V. | $9.2b | $50.38 | +0.3% | 6.5M | |
| BillionToOne, Inc. Class A Common Stock | $5.0b | $104.77 | +2.1% | 433.0K | |
| Veracyte, Inc. | $3.7b | $48.02 | +4.1% | 626.3K | |
| CareDx, Inc. | $3.5b | $69.42 | +0.0% | 77.5K | |
| NeoGenomics, Inc. | $2.4b | $16.59 | +1.2% | 1.1M | |
| GeneDx Holdings Corp. Class A Common Stock | $2.2b | $61.36 | -14.3% | 2.3M | |
| Personalis, Inc. Common Stock | $1.7b | $15.60 | +0.2% | 126.3K | |
| Azenta, Inc. | $1.7b | $36.50 | +1.3% | 362.2K | |
| Opko Health Inc. | $1.2b | $1.61 | +1.2% | 1.4M | |
| Pacific Biosciences of California, Inc. | $0.8b | $2.10 | +2.4% | 4.8M | |
| Mesa Laboratories Inc | $0.7b | $128.45 | -0.3% | 81.2K | |
| Fulgent Genetics, Inc. Common Stock | $0.6b | $20.10 | +0.6% | 36.8K | |
| Myriad Genetics Inc | $434.2m | $5.86 | +1.1% | 1.8M | |
| Prenetics Global Limited Class A Ordinary Share | $338.4m | $17.36 | +5.0% | 153.2K | |
| Insight Molecular Diagnostics Inc. Common Stock | $112.6m | $2.85 | +0.4% | 37.9K | |
| Quantum Cyber N.V. Ordinary Shares | $111.8m | $0.98 | -1.0% | 14.9K | |
| ALPS Group Inc Ordinary Share | $65.7m | $0.33 | 0.0% | 18.6K | |
| Bionano Genomics, Inc. Common Stock | $17.4m | $1.16 | -4.2% | 8.0K | |
| BioNexus Gene Lab Corp Common stock | $3.7m | $1.11 | 0.0% | 2.2K |